{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:06:56Z","timestamp":1792415216591,"version":"4.4.0"},"reference-count":124,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Matrix metalloproteinases (MMPs) are endopeptidases that help maintain tissue homeostasis. Dysregulation of MMP secretion or activity, along with issues in their natural regulators, contributes to the development of many disorders, including autoimmune skin diseases. This article provides a comprehensive review of current research on MMP biology, their physiological functions, and disease-specific evidence in dermatology. Based on available English-language studies, we discuss key papers with important findings and the latest systematic reviews from PubMed. Additionally, a comparison, synthesis, and summary of reported results are included to highlight the specific role of MMPs in dermatology and to identify research gaps that need to be addressed for developing and using MMPs as potential biomarkers in skin disease pathophysiology.<\/jats:p>","DOI":"10.3390\/ijms262110319","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:47:36Z","timestamp":1761266856000},"page":"10319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Matrix Metalloproteinases in Inflammatory Dermatoses"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-8130","authenticated-orcid":false,"given":"Joanna","family":"Czerwi\u0144ska","sequence":"first","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-0438","authenticated-orcid":false,"given":"Agnieszka","family":"Owczarczyk-Saczonek","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2008","journal-title":"Mol. Asp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wan, J., Zhang, G., Li, X., Qiu, X., Ouyang, J., Dai, J., and Min, S. (2021). Matrix metalloproteinase 3: A promoting and destabilizing factor in the pathogenesis of disease and cell differentiation. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.663978"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejcb.2014.01.002","article-title":"Metalloproteinases in melanoma","volume":"93","author":"Moro","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"ref_5","first-page":"712","article-title":"Matrix metalloproteinases: From molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"Thode","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"ref_6","first-page":"327","article-title":"Matrix metalloproteinases\u2014Biochemical characteristics and clinical value determination in breast cancer patients","volume":"9","year":"2005","journal-title":"Contemp. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"C1290","DOI":"10.1152\/ajpcell.00450.2021","article-title":"Metalloproteinases in dermal homeostasis","volume":"323","author":"Steinkamp","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2174\/13816128113196660701","article-title":"Metalloproteinases and metalloproteinase inhibitors in age-related diseases","volume":"20","author":"Gargiulo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.matbio.2015.01.002","article-title":"New strategies for targeting matrix metalloproteinases","volume":"44\u201346","author":"Fields","year":"2015","journal-title":"Matrix Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tokito, M., and Jougasaki, M. (2016). Matrix metalloproteinases in non-neoplastic disorders. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071178"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: Innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"H919","DOI":"10.1152\/ajpheart.00577.2012","article-title":"The history of matrix metalloproteinases: Milestones, myths, and misperceptions","volume":"303","author":"Iyer","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0625.1997.tb00164.x","article-title":"Matrix metalloproteinases in skin","volume":"6","year":"1997","journal-title":"Exp. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1021152910976","article-title":"Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma","volume":"77","author":"Hirvonen","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"No\u00ebl, A., Guti\u00e9rrez-Fern\u00e1ndez, A., Sounni, N.E., Behrendt, N., Maquoi, E., Lund, I.K., Cal, S., Hoyer-Hansen, G., and L\u00f3pez-Ot\u00edn, C. (2012). New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Front. Pharmacol., 3.","DOI":"10.3389\/fphar.2012.00140"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1089\/thy.2004.14.881","article-title":"Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines","volume":"14","author":"Baldini","year":"2004","journal-title":"Thyroid"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-006-9022-6","article-title":"Matrix metalloproteinase-9 and autoimmune diseases","volume":"26","author":"Ram","year":"2006","journal-title":"J. Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.0022-202X.2004.23601.x","article-title":"Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts","volume":"124","author":"Jinnin","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopha.2016.12.080","article-title":"MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase-1","volume":"87","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jdermsci.2014.02.002","article-title":"Effects of the immunosuppressant rapamycin on the expression of human \u03b12(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts","volume":"74","author":"Tamaki","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.5114\/ada.2021.113127","article-title":"Concentrations of metalloproteinase-1 in patients with morphea treated with phototherapy: A preliminary study","volume":"39","author":"Lodyga","year":"2022","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_24","first-page":"394","article-title":"Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized scleroderma","volume":"24","author":"Asano","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_25","first-page":"3001","article-title":"Decrease in matrix metalloproteinase 3 activity in systemic sclerosis fibroblasts causes \u03b12-antiplasmin and extracellular matrix deposition, and contributes to fibrosis development","volume":"22","author":"Niwa","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar1454","article-title":"Elevated matrix metalloproteinase-9 in patients with systemic sclerosis","volume":"7","author":"Kim","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/art.42973","article-title":"Targeting CD13\/aminopeptidase N as a novel therapeutic approach for scleroderma fibrosis","volume":"77","author":"Muraoka","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdermsci.2008.04.013","article-title":"Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma","volume":"52","author":"Tomimura","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00403-004-0468-1","article-title":"Serum matrix metalloproteinase-3 in systemic sclerosis","volume":"296","author":"Jinnin","year":"2004","journal-title":"Arch. Dermatol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15049077","DOI":"10.4238\/gmr15049077","article-title":"Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis","volume":"15","author":"Rech","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3892\/ijmm.2011.661","article-title":"Analysis of matrix metalloproteinase-9 gene polymorphism -1562 C\/T in patients suffering from systemic sclerosis with and without ulcers","volume":"27","author":"Skarmoutsou","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"ref_32","first-page":"191","article-title":"Matrix metalloproteinase 7 is a candidate biomarker","volume":"45","author":"Xu","year":"2020","journal-title":"Acta Reum. Port."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2101560","DOI":"10.1183\/13993003.01560-2021","article-title":"The prognostic role of matrix metalloproteinase-7 in scleroderma-associated interstitial lung disease","volume":"58","author":"Matson","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s10020-025-01128-2","article-title":"Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: Towards an earlier and accurate diagnosis","volume":"31","author":"Blanco","year":"2025","journal-title":"Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/00220345241249408","article-title":"Orofacial Complications of the Connective Tissue Disease Systemic Sclerosis","volume":"103","author":"Sharma","year":"2024","journal-title":"J. Dent. Res."},{"key":"ref_36","first-page":"1254","article-title":"Expression of genes for metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis","volume":"47","author":"Starodubtseva","year":"2011","journal-title":"Genetika"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9913798","DOI":"10.1155\/2021\/9913798","article-title":"Assessment of Selected Matrix Metalloproteinases (MMPs) and Correlation with Cytokines in Psoriatic Patients","volume":"2021","author":"Raczkiewicz","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5021\/ad.2009.21.1.27","article-title":"The Increased Expression of Matrix Metalloproteinase-9 Messenger RNA in the Non-lesional Skin of Patients with Large Plaque Psoriasis Vulgaris","volume":"21","author":"Lee","year":"2009","journal-title":"Ann. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/exd.13149","article-title":"Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes","volume":"26","author":"Stjernholm","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_40","first-page":"17","article-title":"Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales","volume":"86","author":"Flisiak","year":"2006","journal-title":"Acta Derm. Venereol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00403-012-1251-3","article-title":"Modification of osteopontin and MMP-9 levels in patients with psoriasis on anti-TNF-\u03b1 therapy","volume":"304","author":"Buommino","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jid.2020.09.006","article-title":"MMP-9 Mediates Cross-Talk between Neutrophils and Endothelial Cells in Psoriasis","volume":"141","author":"Ryffel","year":"2021","journal-title":"J. Investig. Dermatol."},{"key":"ref_43","first-page":"27","article-title":"Expression of matrix metalloproteases in psoriasis and atherosclerosis","volume":"16","author":"Sautin","year":"2013","journal-title":"Russ. J. Ski. Venereol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Su, W., Zhao, Y., Wei, Y., Zhang, X., Ji, J., and Yang, S. (2021). Exploring the Pathogenesis of Psoriasis Complicated With Atherosclerosis via Microarray Data Analysis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.667690"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/bmm-2018-0169","article-title":"Role of polymorphisms in MMP-9 and TIMP-1 as biomarkers for susceptibility to systemic lupus erythematosus patients","volume":"13","author":"Vira","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_46","first-page":"261","article-title":"Expression of the matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in systemic lupus erythematosus patients","volume":"78","author":"Vira","year":"2020","journal-title":"Neth. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/0961203312436857","article-title":"Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients","volume":"21","author":"Bahrehmand","year":"2012","journal-title":"Lupus"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0961203314559085","article-title":"Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: Correlation with systemic inflammatory markers and oxidative stress","volume":"24","author":"Bahrehmand","year":"2015","journal-title":"Lupus"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9796735","DOI":"10.1155\/2019\/9796735","article-title":"Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-analysis","volume":"2019","author":"Lee","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_50","first-page":"58","article-title":"Matrix metalloproteinase-3 in patients with systemic lupus erythematosus and its significance in differentiating disease activity from pulmonary infections","volume":"59","author":"Li","year":"2020","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.41506","article-title":"Association of Urinary Matrix Metalloproteinase 7 Levels with Incident Renal Flare in Lupus Nephritis","volume":"73","author":"Wang","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2249.2002.01758.x","article-title":"Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus","volume":"127","author":"Sthoeger","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2174\/1381612824666180607123431","article-title":"Circulating Matrix Metalloproteinase-9 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis","volume":"24","author":"Mao","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00403-018-1811-2","article-title":"Matrix metalloproteinase-2 and -9 activity levels increase in cutaneous lupus erythematosus lesions and correlate with disease severity","volume":"310","author":"Ertugrul","year":"2018","journal-title":"Arch. Dermatol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0961203309356455","article-title":"Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus","volume":"19","author":"Lesiak","year":"2010","journal-title":"Lupus"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/1523-1747.ep12518285","article-title":"Demonstration of Collagenase and Elastase Activities in the Blister Fluids from Bullous Skin Diseases. Comparison Between Dermatitis Herpetiformis and Bullous Pemphigoid","volume":"81","author":"Olkarinen","year":"1983","journal-title":"J. Investig. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.188.3.475","article-title":"Gelatinase B\u2013deficient Mice Are Resistant to Experimental Bullous Pemphigoid","volume":"188","author":"Liu","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1523-1747.ep12363823","article-title":"Demonstration of 72-kDa and 92-kDa Forms of Type IV Collagenase in Human Skin: Variable Expression in Various Blistering Diseases, Induction During Re-Epithelialization, and Decrease by Topical Glucocorticoids","volume":"101","author":"Oikarinen","year":"1993","journal-title":"J. Investig. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.0022-202x.2001.01521.x","article-title":"Respective contribution of neutrophil elastase and matrix met-alloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid","volume":"117","author":"Verraes","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8635158","article-title":"The Role of Matrix Metalloproteinases (MMP-2 and MMP-9) in Ageing and Longevity: Focus on Sicilian Long-Living Individuals (LLIs)","volume":"2020","author":"Cancemi","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Riani, M., Muller, C., Bour, C., Bernard, P., Antonicelli, F., and Le Jan, S. (2019). Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01858"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0092-8674(00)00087-8","article-title":"The Serpin \u03b11-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B\/MMP-9 In Vivo","volume":"102","author":"Liu","year":"2000","journal-title":"Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI23977","article-title":"Synergy between a plasminogen cascade and MMP-9 in autoimmune disease","volume":"115","author":"Liu","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen","volume":"93","author":"Inoue","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/jid.2014.263","article-title":"Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid","volume":"134","author":"Vallerand","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.matbio.2011.09.003","article-title":"Neutrophil elastase cleaves the murine hemidesmosomal protein BP180\/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid","volume":"31","author":"Lin","year":"2012","journal-title":"Matrix Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1242\/jcs.085480","article-title":"MMP9 cleavage of the \u03b24 integrin ectodomain leads to recurrent epithelial erosions in mice","volume":"124","author":"Blanco","year":"2011","journal-title":"J. Cell Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4049\/jimmunol.2300080","article-title":"The Eotaxin-1\/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid","volume":"211","author":"Jordan","year":"2023","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jdermsci.2023.07.008","article-title":"Eosinophil-derived galectin-10 upregulates matrix metalloproteinase expression in bullous pemphigoid blisters","volume":"112","author":"Sato","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jcp.20997","article-title":"Defining the involvement of proteinases in pemphigus vulgaris: Evidence of matrix metalloproteinase-9 overexpression in experimental models of disease","volume":"212","author":"Cirillo","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/exd.13157","article-title":"A possible interaction between periostin and CD163(+) skin-resident macrophages in pemphigus vulgaris and bullous pemphigoid","volume":"26","author":"Fujimura","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Cirillo, N., and Prime, S.S. (2021). A Scoping Review of the Role of Metalloproteinases in the Pathogenesis of Autoimmune Pemphigus and Pemphigoid. Biomolecules, 11.","DOI":"10.3390\/biom11101506"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1601-0825.2006.01287.x","article-title":"Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes","volume":"13","author":"Cirillo","year":"2006","journal-title":"Oral Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-4362.2001.01239.x","article-title":"Identification of clustered cells in human hair follicle responsible for MMP-9 gelatinolytic activity: Consequences for the regulation of hair growth","volume":"40","author":"Jarrousse","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/toxsci\/kfl149","article-title":"Chronic exposure to a trichloroethylene metabolite in autoimmune-prone MRL+\/+ mice promotes immune modulation and alopecia","volume":"95","author":"Blossom","year":"2007","journal-title":"Toxicol. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1365-2133.2002.04848.x","article-title":"Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata","volume":"147","author":"Heffler","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3892\/etm.2016.3319","article-title":"Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle","volume":"12","author":"Hou","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Yu, L., and Li, L. (2022). Potential biomarkers of atopic dermatitis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1028694"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Valenzuela, F., Fern\u00e1ndez, J., Aroca, M., Jim\u00e9nez, C., Albers, D., Hern\u00e1ndez, M., and Fern\u00e1ndez, A. (2020). Gingival Crevicular Fluid Zinc- and Aspartyl-Binding Protease Profile of Individuals with Moderate\/Severe Atopic Dermatitis. Biomolecules, 10.","DOI":"10.20944\/preprints202010.0005.v1"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/jid.2011.173","article-title":"Matrix metalloproteinase-8 is involved in dermal nerve growth: Implications for possible application to pruritus from in vitro models","volume":"131","author":"Tominaga","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.2009.09467.x","article-title":"A study of matrix metalloproteinase expression and activity in atopic dermatitis using a novel skin wash sampling assay for functional biomarker analysis","volume":"162","author":"Harper","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2230.2007.02378.x","article-title":"Elevated levels of plasma matrix metalloproteinase--9 in patients with atopic dermatitis: A pilot study","volume":"32","author":"Devillers","year":"2007","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.jid.2024.01.013","article-title":"Matrix Metalloproteinase 9 Plays a Crucial Role in Inflammation and Itch in Allergic Contact Dermatitis by Regulating Toll-Like Receptor 2\/1 Signaling","volume":"144","author":"Wang","year":"2024","journal-title":"J. Investig. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"773","DOI":"10.5114\/ada.2021.110043","article-title":"Assessment of serum concentrations of matrix metalloproteinase 1,matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases 1 in atopic dermatitis in correlation with disease severity and epidermal barrier parameters","volume":"38","author":"Lis","year":"2021","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1111\/jdv.13825","article-title":"Impaired CD23 and CD62L expression and tissue inhibitors of metalloproteinases secretion by eosinophils in adults with atopic dermatitis","volume":"30","author":"Orfali","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Pereira da Fonseca, A., Traidl, S., Gutzmer, R., Schaper-Gerhardt, K., Werfel, T., and Mommert, S. (2024). Histamine and Th2 cytokines independently and synergistically upregulate MMP12 expression in human M2 macrophages. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1429009"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Wang, J., Huang, Y., Wu, X., and Li, D. (2024). MicroRNA-939 amplifies Staphylococcus aureus-induced matrix metalloproteinase expression in atopic dermatitis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1354154"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Deng, J., Parthasarathy, V., Marani, M., Bordeaux, Z., Lee, K., Trinh, C., Cornman, H.L., Kambala, A., Pritchard, T., and Chen, S. (2022). Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1022889"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/eji.200737855","article-title":"Monocyte-dependent oncostatin M and TNF-alpha synergize to stimulate unopposed matrix metalloproteinase-1\/3 secretion from human lung fibroblasts in tuberculosis","volume":"38","author":"Elkington","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Shao, Y., Wang, D., Zhu, Y., Xiao, Z., Jin, T., Peng, L., Shen, Y., and Tang, H. (2023). Molecular mechanisms of pruritus in prurigo nodularis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1301817"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kalantar, M., Hilpert, G.A., Mosca, E.R., and Raeeszadeh-Sarmazdeh, M. (2024). Engineering metalloproteinase inhibitors: Tissue inhibitors of metalloproteinases or antibodies, that is the question. Curr. Opin. Biotechnol., 86.","DOI":"10.1016\/j.copbio.2024.103094"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-5793(00)01528-3","article-title":"The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3","volume":"473","author":"Amour","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_95","first-page":"32","article-title":"Metaloproteinazy macierzy zewn\u0105trzkom\u00f3rkowej MMP1, MMP2, MMP9 oraz ich inhibitory tkankowe TIMP1, TIMP2, TIMP3 w rakach g\u0142owy i szyi: Badanie immunohistochemiczne","volume":"70","author":"Pietruszewska","year":"2016","journal-title":"Otolaryngol. Pol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2005.04.044","article-title":"Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18","volume":"23","author":"Leighl","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cabral-Pacheco, G.A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acu\u00f1a, J.M., Perez-Romero, B.A., Guerrero-Rodriguez, J.F., Martinez-Avila, N., and Martinez-Fierro, M.L. (2020). The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249739"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"39497","DOI":"10.1074\/jbc.M005932200","article-title":"Domain interactions in the Gelatinase A\u00b7TIMP-2\u00b7MT1-MMP activation complex","volume":"275","author":"Overall","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Raeeszadeh-Sarmazdeh, M., Do, L.D., and Hritz, B.G. (2020). Metalloproteinases and their inhibitors: Potential for the development of new therapeutics. Cells, 9.","DOI":"10.3390\/cells9051313"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1007\/s00018-019-03338-4","article-title":"Homotrimeric MMP-9 is an active hitchhiker on alpha-2-macroglobulin partially escaping protease inhibition and internalization through LRP-1","volume":"77","author":"Serifova","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Mendes, S.R., Amo-Maestro, L.D., Marino-Puertas, L., Diego, I., Goulas, T., and Gomis-R\u00fcth, F.X. (2020). Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-63338-4"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Palladini, G., Di Pasqua, L.G., Croce, A.C., Ferrigno, A., and Vairetti, M. (2023). Recent updates on the therapeutic prospects of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) in liver injuries. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417407"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-3083.2004.00863.x","article-title":"C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis","volume":"18","author":"Chodorowska","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_104","first-page":"35","article-title":"Plasma alpha-2-macroglobulin level in moderate to severe psoriasis","volume":"10","author":"Sikder","year":"2011","journal-title":"Bangladesh J. Med. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Sch\u00f6n, M.P. (2019). Adaptive and innate immunity in psoriasis and other inflammatory disorders. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01764"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Freire, M., Sope\u00f1a, B., Bravo, S., Spuch, C., Argibay, A., Est\u00e9vez, M., Pena, C., Naya, M., Lama, A., and Gonz\u00e1lez-Quintela, A. (2025). Serum proteomic markers in patients with systemic sclerosis in relation to silica exposure. J. Clin. Med., 14.","DOI":"10.3390\/jcm14062019"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez, J., Droppelmann, C.A., Contreras, O., Takahashi, C., and Brandan, E. (2015). RECK-mediated \u03b21-integrin regulation by TGF-\u03b21 is critical for wound contraction in mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135005"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0896-8411(03)00037-4","article-title":"Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"20","author":"Matache","year":"2003","journal-title":"J. Autoimmun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"17898","DOI":"10.1155\/MI\/2006\/17898","article-title":"Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythematosus","volume":"2006","author":"Robak","year":"2006","journal-title":"Mediat. Inflamm."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Asano, T., Ito, H., Kariya, Y., Hoshi, K., Yoshihara, A., Ugawa, Y., Sekine, H., Hirohata, S., Yamaguchi, Y., and Sato, S. (2017). Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186414"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s10020-025-01124-6","article-title":"miR-6516-3p-mediated downregulation of the endogenous MMP-9 inhibitor RECK in mesangial cells might exacerbate lupus nephritis","volume":"31","author":"Tomita","year":"2025","journal-title":"Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2249.2002.01740.x","article-title":"Increased levels of serum tissue inhibitor of metalloproteinase-1 but not metalloproteinase-3 in atopic dermatitis","volume":"127","author":"Katoh","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1346-8138.2005.tb00905.x","article-title":"Beneficial effects of tissue inhibitor of metalloproteinases-2 (TIMP-2) on chronic dermatitis","volume":"32","author":"Miyoshi","year":"2005","journal-title":"J. Dermatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.25208\/0042-4609-2014-90-4-35-39","article-title":"Acute inflammation phase proteins in cases of IgE-mediated and IgE-independent atopic dermatitis","volume":"90","author":"Burdina","year":"2017","journal-title":"Vestn. Dermatol. Venerol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjp.0703751","article-title":"Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor","volume":"131","author":"Hamada","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_116","first-page":"1110","article-title":"RXP470.1, a selective MMP-12 inhibitor, reduces atherosclerotic plaque area and promotes plaque stability in ApoE-deficient mice","volume":"121","author":"Johnson","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1161\/01.CIR.0000069331.67148.2F","article-title":"New frontiers in cardiology: Drug-eluting stents: Part II","volume":"107","author":"Sousa","year":"2003","journal-title":"Circulation"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01757357","article-title":"Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine","volume":"44","author":"Norga","year":"1995","journal-title":"Inflamm. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/135245859800400206","article-title":"Toxicity in a double-blind, placebo-controlled pilot trial with D-penicillamine and metacycline in secondary progressive multiple sclerosis","volume":"4","author":"Dubois","year":"1998","journal-title":"Mult. Scler."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/ije-2017-0018","article-title":"Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing","volume":"4","author":"Metz","year":"2017","journal-title":"Int. J. Endocr. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phrs.2010.12.003","article-title":"Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD)","volume":"63","author":"Caton","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-11-4149","article-title":"Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth","volume":"72","author":"Remacle","year":"2012","journal-title":"Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-1-0716-2285-8_19","article-title":"Engineering tissue inhibitors of metalloproteinases using yeast surface display","volume":"2491","author":"Toumaian","year":"2022","journal-title":"Methods Mol. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10319\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:49:41Z","timestamp":1761266981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":124,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110319"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110319","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}